Ambarella Inc: Form 10-Q for the period ended Apr 30, 2025
Filed with the SEC on Jun 3, 2025 and accepted by EDGAR at Jun 3, 2025, 14:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-02-01 to 2025-04-30 | $85.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-02-01 to 2025-04-30 | $34.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-02-01 to 2025-04-30 | $51.5m | us-gaap:GrossProfit |
| Research and development | 3 months2025-02-01 to 2025-04-30 | $58.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-02-01 to 2025-04-30 | $18.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-02-01 to 2025-04-30 | −$25.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-02-01 to 2025-04-30 | $645.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-02-01 to 2025-04-30 | −$24.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-02-01 to 2025-04-30 | −$0.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-02-01 to 2025-04-30 | −$0.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-02-01 to 2025-04-30 | 42,219,972 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-02-01 to 2025-04-30 | $14.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-02-01 to 2025-04-30 | $4.6m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2025-02-01 to 2025-04-30 | $1.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-04-30 | $141.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-04-30 | $335.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-04-30 | $701.9m | us-gaap:Assets |
| Current liabilities | At period end2025-04-30 | $124.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-04-30 | $129.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-04-30 | $572.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-080767. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.